Commit To Purchase Stemline Therapeutics At $12.50, Earn 11.7% Annualized Using Options
December 01, 2014 at 11:48 AM EST
Investors considering a purchase of Stemline Therapeutics Inc (STML) shares, but tentative about paying the going market price of $14.47/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June 2015 put at the $12.50 strike, which has a bid at the time of this writing of 80 cents..